CDC logo, Safer Healthier People  CDC HomeCDC SearchCDC Health Topics A-Z
NIOSH - National Institute for Occupational Safety and Health

Search NIOSH  |  NIOSH Home  |  NIOSH Topics  |  Site Index  |  Databases and Information Resources  |  NIOSH Products  |  Contact Us






5 - Thia - 1 - azabicyclo (4.2.0) oct - 2 - ene - 2 - carboxylic acid, 7 - ( ( (2 - amino - 4 - thiazolyl) (methoxyimino) acetyl) amino) - 8 - oxo - 3 - ( ( (1,2,5,6 - tetrahydro - 2 - methyl - 5,6 - dioxo - 1,2,4 - triazin - 3 - yl) thio) methyl) - , (6R - (6alpha,7beta (Z) ) ) -

RTECS #: XI0368400

CAS #: 73384-59-5


UPDATE: August 2007 MW: 554.62 MF: C18H18N8O7S3


NOTE:

TABLE OF CONTENTS:
  1. SYNONYMS:
  2. ACUTE TOXICITY DATA:
  3. OTHER MULTIPLE DOSE DATA:
  4. REVIEWS:
  5. REFERENCES:

SYNONYMS:

  1. Biotrakson
  1. Ceftriaxone


SKIN AND EYE IRRITATION DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
N/R
N/R N/R N/R


MUTATION DATA AND REFERENCES:

SYSTEM TEST ROUTE/
ORGANISM/
TISSUE
DOSE REFERENCE
N/R N/R N/R N/R


REPRODUCTIVE EFFECTS DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
N/R
N/R N/R N/R


TUMORIGENIC DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
N/R
N/R N/R N/R


ACUTE TOXICITY DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
intramuscular
man
lowest published toxic dose: 14,286 µg/kg Behavioral: Hallucinations, distorted perceptions

Cardiac: Arrythmias (indlucing changes in conduction)

Lung, Thorax, or Respiration: Dyspnea
LLRGDY 55,415,2000
intravenous
human
lowest published toxic dose: 28 mg/kg Gastrointestinal: Hypermotility, diarrhea VCVPS* -,399,1998
intravenous
mouse
lethal dose (50 percent kill): 2.8 gm/kg N/R VCVPS* -,399,1998
intravenous
rat
lethal dose (50 percent kill): 2 gm/kg N/R VCVPS* -,399,1998
intravenous
rabbit
lethal dose (50 percent kill): 240 mg/kg N/R VCVPS* -,399,1998


OTHER MULTIPLE DOSE DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
intramuscular
human
lowest published toxic dose: 98 mg/kg/7 day- intermittent Blood: Other changes

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases
VCVPS* -,400,1998
intramuscular
human
lowest published toxic dose: 140 mg/kg/10 day- intermittent Gastrointestinal: Hypermotility, diarrhea

Gastrointestinal: Nausea or vomiting

Skin: After systemic exposure: Dermatitis, allergic
VCVPS* -,400,1998
intravenous
monkey
lowest published toxic dose: 840 mg/kg/2 week- intermittent Gastrointestinal: Hypermotility, diarrhea VCVPS* -,399,1998
intravenous
monkey
lowest published toxic dose: 72.8 gm/kg/26 week- intermittent Kidney, Ureter, and Bladder: Renal function tests depressed VCVPS* -,399,1998
intravenous
rat
lowest published toxic dose: 111.5 gm/kg/13 week- intermittent Vascular: Acute arterial occulsion VCVPS* -,399,1998


REVIEWS:

ORGANIZATION STANDARD
REFERENCE

TOXICOLOGY REVIEW
MUREAV 488,151,2001
TOXICOLOGY REVIEW
PHMREP 51,211,2005
TOXICOLOGY REVIEW
EMMUEG 43,143,2004
TOXICOLOGY REVIEW
CLTHE* 28,1857,2006


STANDARDS AND REGULATIONS:

ORGANIZATION STANDARD
REFERENCE

N/R N/R N/R


NIOSH DOCUMENTATION AND SURVEILLANCE:

ORGANIZATION STANDARD or SURVEY
REFERENCE

N/R N/R N/R


STATUS IN FEDERAL AGENCIES:

ORGANIZATION
REFERENCE

N/R


REFERENCES:

CODEN
REFERENCE

CLTHE* Clinical Therapeutics : The International Peer-Reviewed Journal of Drug Therapy (Elsevier, USA) V.17- 1995-
EMMUEG Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987-
LLRGDY Allergy. (Munksgaard International Publishers Ltd., POB 2148, 35 Norre Sogade, DK-1016 Copenhagen K, Denmark) V.33- 1978-
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964-
PHMREP Pharmacological Research. (Academic Press, 24-28 Oval Rd. London NW1 7DX, UK) V.21- 1989-
VCVPS* "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998.

Used as an antibacterial agent

RTECS Compound Description:
   Drug
   Human Data

Click Here for Additional Information about RTECS

NIOSH Home |  NIOSH Search  |  Site Index  |  Topic List |  Contact Us